Ivory Graft Revenue

Medical Equipment Manufacturing • Kfar Saba, Center District, Israel • 1-10 Employees

Ivory Graft revenue & valuation

Annual revenue	$427,775
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$1,400,000
Total funding	No funding

Key Contact at Ivory Graft

Denis Cengich

Quality Assurance and Regulations Affairs Director

Company overview

Headquarters	Kfar Saba, Center District, Israel
Phone number	+9724453001
Website	ivorygraft.com
NAICS	3391
Keywords	Dental, Dental Implants, Medical Device Manufacturing, Implantology, Bone Grafts, Sinus Lift, Osteoconductive, GBR, Bone Formation, Dentin, Dentine, Ankylosis, Dentin Graft, Graft Materials
Employees	1-10
Socials

Ivory Graft Email Formats

Ivory Graft uses 3 email formats. The most common is {first name} (e.g., john@ivorygraft.com), used 57.1% of the time.

Format	Example	Percentage
{first name}	john@ivorygraft.com	57.1%
{first initial}	j@ivorygraft.com	28.6%
{first initial}.{last name}	j.doe@ivorygraft.com	14.3%

About Ivory Graft

Ivory Graft Ltd. has developed a naturally sourced, bioresorbable dentin graft material for the repair and augmentation of bone defects. Privately held, the company was founded and is funded by leading clinicians and industry leaders. Located in central Israel, Ivory Graft benefits from the country’s innovative medical startup ecosystem. Ivory Dentin Graft™ - The First and Only Dentin Graft The Ivory Dentin Graft™ was developed based upon years of scientific research and peer-reviewed publications on the advantages of autologous dentin grafts. Dentin’s composition is very similar to bone, due to its high mineral phase and its tubular architecture. Dentin is considered an excellent bone graft substitute grafting material. Ivory Dentin Graft is an active organic matrix. It retains the natural form of the sourced porcine dentin as well as the protein matrix consisting largely of collagen, and has been adapted for use in dental procedures. For the best results and ideal hard tissue generation, physicomechanical properties of the graft should match that of the host bone, in addition to biological connectivity and bio-active organic matrix. Ivory Dentin Graft promotes new bone formation as well as promoting good integration between the host-bone and graft material. These two features are important for tissue regeneration and integration during early bone remodeling processes that follow tooth extraction and grafting, and facilitate osteogenic activity to promote successful subsequent implant placement. CE Marked (MDR 2017/745), Ivory Dentin Graft™ is a graft substitute, naturally sourced from porcine dentin, obtained by standardized and controlled manufacturing procedures. This unique dentin graft is safe and effective, has no additives, and carries no BSE risk. In the USA, Ivory Dentin Graft™ is not yet available for commercial use .

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Ivory Graft has never raised funding before.

Frequently asked questions

Ivory Graft is located in Kfar Saba, Center District, IL.

You can reach Ivory Graft at +9724453001.

Ivory Graft generates an estimated annual revenue of $427,775. This revenue figure reflects the company's market position and business performance in its industry.

Ivory Graft has an estimated valuation of $1,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Ivory Graft has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Ivory Graft

Denis Cengich

Quality Assurance and Regulations Affairs Director

4.8

40,000 users